Clinical trial
A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other…
NCT00002332 · Immunobiology Research Institute, Industry · Completed
Key facts
| NCT number | NCT00002332 |
|---|---|
| Title | A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs |
| Official title | Double-Blind Study of the Effect of Timunox (Thymopentin) on Lymphoproliferative Responses and Virus Load in HIV-Infected Subjects Receiving Nucleoside Analog Antiretroviral Therapy |
| Lead sponsor | Immunobiology Research Institute, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Thymopentin |
| Enrollment | 60 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: